Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Double acupuncture approach may tackle obesity

NCT ID NCT07770893

Disease control Sponsor: Taipei City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time

Summary

This trial tests whether adding laser acupuncture to a standard acupuncture technique—thread embedding—can enhance weight loss in adults with obesity. Participants receive the same thread embedding treatment, but half also get active laser acupuncture while the other half gets a sham (inactive) laser, to isolate the laser's true effect. The study tracks weight, body mass index, and other health markers over 12 weeks of treatment plus a 12-week follow-up.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Acupoint catgut embedding (thread embedding acupuncture) combined with 810 nm laser acupuncture
What this could lead to
If effective, this combination could offer a non-drug, low-risk option to help adults with obesity lose weight and improve related health measures.
What could go wrong
This is a relatively small, early-stage trial, and the sham-controlled design means the added benefit of the laser is uncertain. Results may not apply to all people with obesity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 20 to 65 years * Body mass index of 27 kg/m\^2 or greater, or body mass index of 24 kg/m\^2 or greater together with a waist circumference of 90 cm or greater in men or 80 cm or greater in women * Able to fully understand the informed consent document and willing to give written informed consent * No use of weight-loss medication and no other weight-reduction treatment in the 3 months before enrollment * Willing to follow the dietary and exercise advice given during the trial Exclusion Criteria: * Current use of medication that may affect body weight, including corticosteroids, antipsychotics, insulin, or glucagon-like peptide-1 (GLP-1) receptor agonists * Known secondary cause of obesity, such as hypothyroidism, Cushing syndrome, or pituitary disease * Severe cardiovascular, hepatic, or renal disease, or poorly controlled diabetes defined as glycated hemoglobin (HbA1c) above 9 percent * Currently pregnant, breastfeeding, or planning pregnancy within 6 months * Bariatric surgery within the previous 6 months * Known allergy to absorbable suture material * Skin infection at the embedding sites, keloid tendency, or coagulation disorder * Implanted cardiac pacemaker or other electromagnetic implant * Known photosensitivity disorder or current use of photosensitizing medication

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Obesity, Abdominal Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity Obesity, abdominal Overweight

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Taipei City Hospital, Renai Branch

    Taipei, 106, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.